A.R.T. Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
A.R.T. Advisors's GILD Position: Q1 2021 in Review
A.R.T. Advisors sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 8,200 shares — an estimated $478K sold.
A.R.T. Advisors first reported a position in GILD in Q2 2013 and held it in 16 quarters. The position peaked at $16.6M in Q4 2015. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.
- A.R.T. Advisors reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
- A.R.T. Advisors sold 8,200 Gilead Sciences shares in Q1 2021, an estimated $478K.
- A.R.T. Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 16 quarters.
- A.R.T. Advisors's Gilead Sciences position peaked at $16.6M in Q4 2015.
- 1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.
Based on A.R.T. Advisors's 13F filing for Q1 2021, filed 17 May 2021.